Getting to transplant in Hodgkin lymphoma: BVB

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


In this issue of Blood, LaCasce et al present data on the incorporation of brentuximab vedotin (BV) with bendamustine (BVB) in patients with recurrent/refractory classical Hodgkin lymphoma (HL) that might be practice-changing.1

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
Issue number1
StatePublished - Jul 5 2018

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Getting to transplant in Hodgkin lymphoma: BVB'. Together they form a unique fingerprint.

Cite this